Lescarden Inc (LCAR) financial statements (2021 and earlier)

Company profile

Business Address 420 LEXINGTON AVE.
NEW YORK, NY 10170
State of Incorp. NY
Fiscal Year End May 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

2/28/2017
Q3
11/30/2016
Q2
8/31/2016
Q1
5/31/2016
Q4
2/29/2016
Q3
11/30/2015
Q2
8/31/2015
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments891672743676
Cash and cash equivalents891672743676
Receivables121329512247
Inventory, net of allowances, customer advances and progress billings6643481981588682
Inventory6643481981588682
Total current assets:16722336920419595134
Noncurrent Assets
TOTAL ASSETS:16722336920419595134
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:257258305309277183187
Accounts payable 258305 277183187
Other undisclosed accounts payable and accrued liabilities257  309   
Debt269269329279269269269
Total current liabilities:526527634588546451456
Noncurrent Liabilities
Total liabilities:526527634588546451456
Stockholders' equity
Stockholders' equity attributable to parent, including:(359)(305)(264)(385)(350)(357)(321)
Common stock64646464646464
Additional paid in capital17,50617,50617,50617,50617,50617,50617,506
Accumulated deficit(17,930)(17,876)(17,836)(17,956)(17,922)(17,928)(17,893)
Other undisclosed stockholders' equity attributable to parent2222222
Total stockholders' equity:(359)(305)(264)(385)(350)(357)(321)
TOTAL LIABILITIES AND EQUITY:16722336920419595134

Income statement (P&L) ($ in thousands)

2/28/2017
Q3
11/30/2016
Q2
8/31/2016
Q1
5/31/2016
Q4
2/29/2016
Q3
11/30/2015
Q2
8/31/2015
Q1
Revenues
(Revenue, Net)
25423507701032
Cost of revenue(4)(6)(159)(26)(5)(1)(1)
Cost of goods and services sold(4)(6)(159) (5)(1)(1)
Gross profit:2136191(19)65931
Operating expenses(71)(73)(70)(16)(59)(44)(80)
Operating income (loss):(50)(37)120(34)6(35)(49)
Interest and debt expense(4)(4)     
Other undisclosed loss from continuing operations before equity method investments, income taxes   (0)   
Net income (loss):(54)(40)120(35)6(35)(49)
Other undisclosed net income attributable to parent   0   
Net income (loss) available to common stockholders, diluted:(54)(40)120(34)6(35)(49)

Comprehensive Income ($ in thousands)

2/28/2017
Q3
11/30/2016
Q2
8/31/2016
Q1
5/31/2016
Q4
2/29/2016
Q3
11/30/2015
Q2
8/31/2015
Q1
Net income (loss):(54)(40)120(35)6(35)(49)
Comprehensive income (loss), net of tax, attributable to parent:(54)(40)120(35)6(35)(49)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: